Serotonin/norepinephrine/dopamine transporters (SERT/NET/DAT)

Class

Triple monoamine reuptake inhibitor

Serotonin, norepinephrine, and dopamine are neurotransmitters released by neurons to signal mood, arousal, motivation, and attention circuits in the brain. After release, their action is terminated by dedicated transporter proteins—SERT, NET, and DAT—that pump the neurotransmitter back into the releasing neuron for recycling. A triple reuptake inhibitor blocks all three transporters simultaneously, slowing this reuptake process and allowing higher and more sustained levels of all three neurotransmitters in the synapse, the small gap between neurons where signaling occurs. This broad approach is rooted in the observation that mood and motivation disorders, particularly depression, often involve deficits spanning multiple monoamine systems rather than just one. Selective agents that block only serotonin reuptake (as with many older antidepressants) do not always address symptoms like low energy, poor concentration, or anhedonia (loss of pleasure), which are more closely tied to dopamine and norepinephrine signaling. By engaging all three systems, triple reuptake inhibitors aim to produce a broader symptomatic response than single- or dual-transporter agents, though this breadth also raises the potential for a wider range of on-target physiological effects. This class is studied primarily in mood disorders and related conditions where multi-system monoamine deficits are implicated.